Zentalis Pharmaceuticals, Inc. ($ZNTL)
Filing Information
| Accession Number | 0001213900-26-091823 |
|---|---|
| Form Type | 4 |
| Filing Date | Aug 19, 2026 |
| Document | View SEC Filing |
Transactions
1
Total Shares
4,335,000
Total Value
$15,172,500.00
P&L
+9.1% (+$1,387,200.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
10% Owner | Common Stock | โ | Aug 14, 2026 | Purchase | 4,335,000 | $3.50 | $15,172,500.00 | 17,844,973 | Direct | โ | View Details |